BioELife Corp.
LITH
$0.00
$0.000.00%
OTC PK
| 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | 09/30/2018 | |
|---|---|---|---|---|---|
| Net Income | -- | -36,071.43% | 12.09% | -36.51% | 139.64% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -88.65% | -68.37% | -44.42% | -27.73% |
| Total Other Non-Cash Items | -- | 262.21% | -- | -- | -- |
| Change in Net Operating Assets | -- | -30.30% | 12.11% | -5.90% | -58.66% |
| Cash from Operations | -- | 21.88% | 28.47% | 37.76% | -49.53% |
| Capital Expenditure | -- | -127.71% | -3,700.00% | -500.00% | 197.64% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -16.20% | -13.86% | 59,800.00% | 339.48% |
| Total Debt Issued | -- | -100.00% | -100.00% | -82.61% | -67.19% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -100.00% | -82.61% | -67.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -167.91% | -164.01% | 152.86% | 1,192.31% |